Page 67 - Michael Erman News Today

HEALTH-CORONAVIRUS/PFIZER-VARIANT (UPDATE 6, PIX):UPDATE 6-Studies suggest Pfizer shot may protect only partially against Omicron

By Julie Steenhuysen (Reuters) - Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible to the rapid cha...

By Michael Erman

Americans are lining up for booster doses of COVID-19 vaccines at a record pace, with concerns about the newly-detected Omicron coronavirus variant spurring millions to get shots, the U.S. government said on Tuesday.

Moderna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Moderna President Stephen Hoge said he believes booster shots carrying genes specifically targeting mutations in the newly-discovered Omicron variant would be the quickest way to address any anticipated reductions in vaccine efficacy it may cause. The company is also working on a multi-valent vaccine that ...

© Reuters. FILE PHOTO: An experimental COVID-19 treatment pill called molnupiravir and developed by Merck & Co Inc and Ridgeback Biotherapeutics LP is

By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) - Moderna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and re...

The United States identified its first COVID-19 case caused by the Omicron variant in California, the U.S. Centers for Disease Control and Prevention said on Wednesday.

The United States identified its first COVID-19 case caused by the Omicron variant in California, the U.S. Centers for Disease Control and Prevention said on Wednesday.

The United States identified its first COVID-19 case caused by the Omicron variant in California, the U.S. Centers for Disease Control and Prevention said on Wednesday.